Skip to content

Alto Ingredients, Inc. ALTO Weighted Average Number Of Shares Dilutive Securities

Weighted Average Number Of Shares Dilutive Securities at other companies

Belden logo
BeldenBDC
39.4M-3.5%
Evommune
 logo
Evommune EVMN
85.1M+1,171%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
179.8M+6.3%
Evommune
 logo
Evommune EVMN
85.1M+1,171%
The Bancorp logo
The BancorpTBBK
42.6M-11.2%
CLB
Core LaboratoriesCLB
46.1M-1.5%

Other financials

Income statement

See full
Revenue$224.7M-0.8%
Gross profit$9.2M+610%
Operating income$2.5M+128%
Net income$4.3M+137%
EPS (diluted)$0.05+131%

Balance sheet

See full
Cash & equivalents$21.6M-20.3%
Total debt$91.3M-30.5%
Total equity$249.9M+16.8%
Total assets$386.3M-4.0%

Cash flow

See full
Operating cash flow$4.2M+123%
CapEx$909.0K+70.9%
Free cash flow$3.3M+118%

Valuation

See full
Market cap$385.88M+342%
Enterprise value$455.51M+138%
P/E13.2×
P/S0.4×+0.3×

Profitability

See full
Gross margin5%
Operating margin2.1%+1.2pp
Net margin3.2%+1.9pp
FCF margin3.4%

Returns & leverage

See full
Return on equity12.6%+7.6pp
Debt / equity0.4×-0.2×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Alto Ingredients, Inc. in its filing.

Tagged under the XBRL concept alto:WeightedAverageNumberOfSharesDilutiveSecurities.

The official record: Alto Ingredients, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Ingredients, Inc.'s weighted average number of shares dilutive securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Ingredients, Inc.'s weighted average number of shares dilutive securities?
Alto Ingredients, Inc. (ALTO) reported weighted average number of shares dilutive securities of 1.2M in Q4 2025.
What does weighted average number of shares dilutive securities mean?
The average number of potential common shares that could be issued through the conversion of dilutive securities such as options, warrants, or convertible debt. This figure is used to assess the potential impact of equity dilution on existing shareholders.